nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyamemazine—HTR2A—attention deficit hyperactivity disorder	0.806	1	CbGaD
Cyamemazine—HTR2A—locus ceruleus—attention deficit hyperactivity disorder	0.0122	0.269	CbGeAlD
Cyamemazine—HTR2A—autonomic nervous system—attention deficit hyperactivity disorder	0.00646	0.143	CbGeAlD
Cyamemazine—CHRM2—forebrain—attention deficit hyperactivity disorder	0.00311	0.0689	CbGeAlD
Cyamemazine—HTR2C—forebrain—attention deficit hyperactivity disorder	0.003	0.0664	CbGeAlD
Cyamemazine—CHRM2—cardiovascular system—attention deficit hyperactivity disorder	0.00263	0.0583	CbGeAlD
Cyamemazine—HTR2C—midbrain—attention deficit hyperactivity disorder	0.00198	0.0439	CbGeAlD
Cyamemazine—CHRM2—nervous system—attention deficit hyperactivity disorder	0.00169	0.0374	CbGeAlD
Cyamemazine—HTR2C—nervous system—attention deficit hyperactivity disorder	0.00163	0.0361	CbGeAlD
Cyamemazine—CHRM2—central nervous system—attention deficit hyperactivity disorder	0.00163	0.036	CbGeAlD
Cyamemazine—HTR2C—central nervous system—attention deficit hyperactivity disorder	0.00157	0.0347	CbGeAlD
Cyamemazine—HTR2A—forebrain—attention deficit hyperactivity disorder	0.00151	0.0333	CbGeAlD
Cyamemazine—CHRM2—brain—attention deficit hyperactivity disorder	0.00129	0.0286	CbGeAlD
Cyamemazine—HTR2A—cardiovascular system—attention deficit hyperactivity disorder	0.00127	0.0282	CbGeAlD
Cyamemazine—HTR2C—Amine ligand-binding receptors—DRD3—attention deficit hyperactivity disorder	0.00125	0.00919	CbGpPWpGaD
Cyamemazine—HTR2C—brain—attention deficit hyperactivity disorder	0.00125	0.0276	CbGeAlD
Cyamemazine—CHRM2—Monoamine GPCRs—ADRA2A—attention deficit hyperactivity disorder	0.00124	0.00917	CbGpPWpGaD
Cyamemazine—CHRM2—Monoamine GPCRs—DRD4—attention deficit hyperactivity disorder	0.00123	0.00905	CbGpPWpGaD
Cyamemazine—HTR2C—Amine ligand-binding receptors—ADRA2A—attention deficit hyperactivity disorder	0.00123	0.00904	CbGpPWpGaD
Cyamemazine—HTR2C—Amine ligand-binding receptors—DRD4—attention deficit hyperactivity disorder	0.00121	0.00892	CbGpPWpGaD
Cyamemazine—HTR2A—Amine ligand-binding receptors—HTR1B—attention deficit hyperactivity disorder	0.0012	0.00887	CbGpPWpGaD
Cyamemazine—CHRM2—Amine ligand-binding receptors—HTR1B—attention deficit hyperactivity disorder	0.00118	0.00871	CbGpPWpGaD
Cyamemazine—HTR2A—Monoamine GPCRs—DRD2—attention deficit hyperactivity disorder	0.00117	0.00859	CbGpPWpGaD
Cyamemazine—CHRM2—Monoamine GPCRs—DRD2—attention deficit hyperactivity disorder	0.00114	0.00843	CbGpPWpGaD
Cyamemazine—HTR2C—Amine ligand-binding receptors—DRD2—attention deficit hyperactivity disorder	0.00113	0.00831	CbGpPWpGaD
Cyamemazine—HTR2A—Amine ligand-binding receptors—DRD1—attention deficit hyperactivity disorder	0.00112	0.00824	CbGpPWpGaD
Cyamemazine—CHRM2—Amine ligand-binding receptors—DRD1—attention deficit hyperactivity disorder	0.0011	0.00809	CbGpPWpGaD
Cyamemazine—HTR2A—Amine ligand-binding receptors—DRD3—attention deficit hyperactivity disorder	0.00108	0.00798	CbGpPWpGaD
Cyamemazine—HTR2A—Amine ligand-binding receptors—ADRA2A—attention deficit hyperactivity disorder	0.00106	0.00785	CbGpPWpGaD
Cyamemazine—CHRM2—Amine ligand-binding receptors—DRD3—attention deficit hyperactivity disorder	0.00106	0.00784	CbGpPWpGaD
Cyamemazine—HTR2A—Amine ligand-binding receptors—DRD4—attention deficit hyperactivity disorder	0.00105	0.00775	CbGpPWpGaD
Cyamemazine—CHRM2—Amine ligand-binding receptors—ADRA2A—attention deficit hyperactivity disorder	0.00105	0.0077	CbGpPWpGaD
Cyamemazine—CHRM2—Amine ligand-binding receptors—DRD4—attention deficit hyperactivity disorder	0.00103	0.00761	CbGpPWpGaD
Cyamemazine—HTR2A—midbrain—attention deficit hyperactivity disorder	0.000994	0.022	CbGeAlD
Cyamemazine—HTR2A—Amine ligand-binding receptors—DRD2—attention deficit hyperactivity disorder	0.00098	0.00722	CbGpPWpGaD
Cyamemazine—CHRM2—Amine ligand-binding receptors—DRD2—attention deficit hyperactivity disorder	0.000962	0.00709	CbGpPWpGaD
Cyamemazine—HTR2C—Monoamine GPCRs—HTR2A—attention deficit hyperactivity disorder	0.00094	0.00693	CbGpPWpGaD
Cyamemazine—HTR2A—nervous system—attention deficit hyperactivity disorder	0.000817	0.0181	CbGeAlD
Cyamemazine—CHRM2—Monoamine GPCRs—HTR2A—attention deficit hyperactivity disorder	0.000801	0.00591	CbGpPWpGaD
Cyamemazine—HTR2C—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.00079	0.00582	CbGpPWpGaD
Cyamemazine—HTR2A—central nervous system—attention deficit hyperactivity disorder	0.000787	0.0174	CbGeAlD
Cyamemazine—HTR2A—cerebellum—attention deficit hyperactivity disorder	0.000769	0.017	CbGeAlD
Cyamemazine—CHRM2—G alpha (i) signalling events—GRM7—attention deficit hyperactivity disorder	0.000734	0.00541	CbGpPWpGaD
Cyamemazine—CHRM2—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.000674	0.00496	CbGpPWpGaD
Cyamemazine—HTR2A—brain—attention deficit hyperactivity disorder	0.000625	0.0138	CbGeAlD
Cyamemazine—HTR2A—GPCRs, Other—DRD3—attention deficit hyperactivity disorder	0.000572	0.00422	CbGpPWpGaD
Cyamemazine—CHRM2—GPCRs, Other—DRD3—attention deficit hyperactivity disorder	0.000562	0.00414	CbGpPWpGaD
Cyamemazine—HTR2A—GPCRs, Other—DRD4—attention deficit hyperactivity disorder	0.000556	0.0041	CbGpPWpGaD
Cyamemazine—CHRM2—GPCRs, Other—DRD4—attention deficit hyperactivity disorder	0.000546	0.00402	CbGpPWpGaD
Cyamemazine—HTR2C—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.000536	0.00395	CbGpPWpGaD
Cyamemazine—HTR2C—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.000525	0.00387	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.000521	0.00384	CbGpPWpGaD
Cyamemazine—CHRM2—G alpha (i) signalling events—ADRA2C—attention deficit hyperactivity disorder	0.000492	0.00363	CbGpPWpGaD
Cyamemazine—HTR2A—SIDS Susceptibility Pathways—TPH2—attention deficit hyperactivity disorder	0.00048	0.00354	CbGpPWpGaD
Cyamemazine—CHRM2—SIDS Susceptibility Pathways—TPH2—attention deficit hyperactivity disorder	0.000472	0.00348	CbGpPWpGaD
Cyamemazine—HTR2A—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.000465	0.00343	CbGpPWpGaD
Cyamemazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.000459	0.00338	CbGpPWpGaD
Cyamemazine—Diltiazem—CACNA1C—attention deficit hyperactivity disorder	0.000457	0.0359	CrCbGaD
Cyamemazine—CHRM2—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.000457	0.00337	CbGpPWpGaD
Cyamemazine—HTR2A—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.000456	0.00336	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.000453	0.00334	CbGpPWpGaD
Cyamemazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00045	0.00331	CbGpPWpGaD
Cyamemazine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.000448	0.0033	CbGpPWpGaD
Cyamemazine—CHRM2—Calcium Regulation in the Cardiac Cell—CACNA1C—attention deficit hyperactivity disorder	0.000447	0.0033	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.000444	0.00328	CbGpPWpGaD
Cyamemazine—Acetophenazine—DRD1—attention deficit hyperactivity disorder	0.000415	0.0326	CrCbGaD
Cyamemazine—HTR2A—SIDS Susceptibility Pathways—CHRNA4—attention deficit hyperactivity disorder	0.000413	0.00304	CbGpPWpGaD
Cyamemazine—CHRM2—SIDS Susceptibility Pathways—CHRNA4—attention deficit hyperactivity disorder	0.000406	0.00299	CbGpPWpGaD
Cyamemazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.000399	0.00294	CbGpPWpGaD
Cyamemazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.000391	0.00288	CbGpPWpGaD
Cyamemazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.000391	0.00288	CbGpPWpGaD
Cyamemazine—HTR2A—SIDS Susceptibility Pathways—SNAP25—attention deficit hyperactivity disorder	0.000384	0.00283	CbGpPWpGaD
Cyamemazine—HTR2A—SIDS Susceptibility Pathways—SLC6A4—attention deficit hyperactivity disorder	0.000384	0.00283	CbGpPWpGaD
Cyamemazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.000383	0.00283	CbGpPWpGaD
Cyamemazine—CHRM2—SIDS Susceptibility Pathways—SLC6A4—attention deficit hyperactivity disorder	0.000377	0.00278	CbGpPWpGaD
Cyamemazine—CHRM2—SIDS Susceptibility Pathways—SNAP25—attention deficit hyperactivity disorder	0.000377	0.00278	CbGpPWpGaD
Cyamemazine—Methotrimeprazine—DRD5—attention deficit hyperactivity disorder	0.000372	0.0292	CrCbGaD
Cyamemazine—Propericiazine—DRD1—attention deficit hyperactivity disorder	0.000367	0.0288	CrCbGaD
Cyamemazine—HTR2C—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.000364	0.00268	CbGpPWpGaD
Cyamemazine—CHRM2—GPCRs, Other—HTR2A—attention deficit hyperactivity disorder	0.000356	0.00262	CbGpPWpGaD
Cyamemazine—Methotrimeprazine—ADRA2C—attention deficit hyperactivity disorder	0.000351	0.0275	CrCbGaD
Cyamemazine—HTR2C—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00035	0.00258	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.000342	0.00252	CbGpPWpGaD
Cyamemazine—Propericiazine—ADRA2A—attention deficit hyperactivity disorder	0.000341	0.0267	CrCbGaD
Cyamemazine—CHRM2—G alpha (i) signalling events—HRH3—attention deficit hyperactivity disorder	0.000334	0.00246	CbGpPWpGaD
Cyamemazine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.000318	0.00234	CbGpPWpGaD
Cyamemazine—HTR2A—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.000316	0.00233	CbGpPWpGaD
Cyamemazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.000312	0.0023	CbGpPWpGaD
Cyamemazine—CHRM2—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00031	0.00229	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.000304	0.00224	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.000298	0.0022	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.000297	0.00219	CbGpPWpGaD
Cyamemazine—HTR2C—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.000296	0.00218	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.000295	0.00217	CbGpPWpGaD
Cyamemazine—Acetophenazine—DRD2—attention deficit hyperactivity disorder	0.000293	0.023	CrCbGaD
Cyamemazine—CHRM2—G alpha (i) signalling events—HTR1B—attention deficit hyperactivity disorder	0.000292	0.00215	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.000292	0.00215	CbGpPWpGaD
Cyamemazine—HTR2A—SIDS Susceptibility Pathways—MAOA—attention deficit hyperactivity disorder	0.000289	0.00213	CbGpPWpGaD
Cyamemazine—HTR2C—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.000286	0.00211	CbGpPWpGaD
Cyamemazine—CHRM2—SIDS Susceptibility Pathways—MAOA—attention deficit hyperactivity disorder	0.000284	0.00209	CbGpPWpGaD
Cyamemazine—Chlorpromazine—DRD5—attention deficit hyperactivity disorder	0.000284	0.0223	CrCbGaD
Cyamemazine—HTR2C—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.000281	0.00207	CbGpPWpGaD
Cyamemazine—HTR2A—SIDS Susceptibility Pathways—BDNF—attention deficit hyperactivity disorder	0.000279	0.00205	CbGpPWpGaD
Cyamemazine—HTR2C—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.000278	0.00205	CbGpPWpGaD
Cyamemazine—HTR2A—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.000276	0.00204	CbGpPWpGaD
Cyamemazine—CHRM2—SIDS Susceptibility Pathways—BDNF—attention deficit hyperactivity disorder	0.000274	0.00202	CbGpPWpGaD
Cyamemazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.000272	0.00201	CbGpPWpGaD
Cyamemazine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.000271	0.002	CbGpPWpGaD
Cyamemazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.000271	0.002	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.000267	0.00197	CbGpPWpGaD
Cyamemazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.000266	0.00196	CbGpPWpGaD
Cyamemazine—CHRM2—G alpha (i) signalling events—DRD3—attention deficit hyperactivity disorder	0.000263	0.00194	CbGpPWpGaD
Cyamemazine—HTR2C—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.000259	0.00191	CbGpPWpGaD
Cyamemazine—CHRM2—G alpha (i) signalling events—ADRA2A—attention deficit hyperactivity disorder	0.000259	0.00191	CbGpPWpGaD
Cyamemazine—HTR2A—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.000257	0.00189	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.000256	0.00189	CbGpPWpGaD
Cyamemazine—CHRM2—G alpha (i) signalling events—DRD4—attention deficit hyperactivity disorder	0.000255	0.00188	CbGpPWpGaD
Cyamemazine—Triflupromazine—DRD1—attention deficit hyperactivity disorder	0.000255	0.02	CrCbGaD
Cyamemazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.000253	0.00187	CbGpPWpGaD
Cyamemazine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.000252	0.00186	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.000251	0.00185	CbGpPWpGaD
Cyamemazine—HTR2A—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.000249	0.00183	CbGpPWpGaD
Cyamemazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.000245	0.00181	CbGpPWpGaD
Cyamemazine—HTR2A—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.000244	0.0018	CbGpPWpGaD
Cyamemazine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.000244	0.0018	CbGpPWpGaD
Cyamemazine—HTR2A—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.000241	0.00178	CbGpPWpGaD
Cyamemazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.000241	0.00178	CbGpPWpGaD
Cyamemazine—CHRM2—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00024	0.00177	CbGpPWpGaD
Cyamemazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000238	0.00176	CbGpPWpGaD
Cyamemazine—CHRM2—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.000238	0.00175	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000237	0.00175	CbGpPWpGaD
Cyamemazine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.000237	0.00175	CbGpPWpGaD
Cyamemazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.000237	0.00174	CbGpPWpGaD
Cyamemazine—Acepromazine—DRD1—attention deficit hyperactivity disorder	0.000236	0.0185	CrCbGaD
Cyamemazine—HTR2C—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.000235	0.00173	CbGpPWpGaD
Cyamemazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.000232	0.00171	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.000232	0.00171	CbGpPWpGaD
Cyamemazine—CHRM2—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.000231	0.0017	CbGpPWpGaD
Cyamemazine—Thioproperazine—DRD1—attention deficit hyperactivity disorder	0.00023	0.0181	CrCbGaD
Cyamemazine—CHRM2—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.000228	0.00168	CbGpPWpGaD
Cyamemazine—Mesoridazine—DRD3—attention deficit hyperactivity disorder	0.000228	0.0179	CrCbGaD
Cyamemazine—Pipotiazine—DRD1—attention deficit hyperactivity disorder	0.000227	0.0178	CrCbGaD
Cyamemazine—HTR2A—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.000225	0.00166	CbGpPWpGaD
Cyamemazine—Propiomazine—DRD4—attention deficit hyperactivity disorder	0.000223	0.0175	CrCbGaD
Cyamemazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000222	0.00164	CbGpPWpGaD
Cyamemazine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.000221	0.00163	CbGpPWpGaD
Cyamemazine—Prochlorperazine—DRD3—attention deficit hyperactivity disorder	0.000221	0.0173	CrCbGaD
Cyamemazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00022	0.00162	CbGpPWpGaD
Cyamemazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.000216	0.00159	CbGpPWpGaD
Cyamemazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.000213	0.00157	CbGpPWpGaD
Cyamemazine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.00021	0.00155	CbGpPWpGaD
Cyamemazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.000209	0.00154	CbGpPWpGaD
Cyamemazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.000209	0.00154	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000208	0.00153	CbGpPWpGaD
Cyamemazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000207	0.00152	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000206	0.00152	CbGpPWpGaD
Cyamemazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.000206	0.00152	CbGpPWpGaD
Cyamemazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000203	0.0015	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000202	0.00149	CbGpPWpGaD
Cyamemazine—Fluphenazine—DRD3—attention deficit hyperactivity disorder	0.000199	0.0157	CrCbGaD
Cyamemazine—HTR2C—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000198	0.00146	CbGpPWpGaD
Cyamemazine—Fluphenazine—DRD1—attention deficit hyperactivity disorder	0.000196	0.0154	CrCbGaD
Cyamemazine—HTR2C—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000194	0.00143	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000193	0.00142	CbGpPWpGaD
Cyamemazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000193	0.00142	CbGpPWpGaD
Cyamemazine—Methotrimeprazine—DRD4—attention deficit hyperactivity disorder	0.00019	0.0149	CrCbGaD
Cyamemazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000189	0.00139	CbGpPWpGaD
Cyamemazine—Propiomazine—DRD1—attention deficit hyperactivity disorder	0.000188	0.0148	CrCbGaD
Cyamemazine—HTR2C—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000187	0.00138	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000184	0.00135	CbGpPWpGaD
Cyamemazine—Fluphenazine—ADRA2A—attention deficit hyperactivity disorder	0.000182	0.0143	CrCbGaD
Cyamemazine—Chlorprothixene—DRD3—attention deficit hyperactivity disorder	0.000182	0.0143	CrCbGaD
Cyamemazine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000181	0.00134	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000181	0.00134	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00018	0.00133	CbGpPWpGaD
Cyamemazine—Triflupromazine—DRD2—attention deficit hyperactivity disorder	0.00018	0.0141	CrCbGaD
Cyamemazine—HTR2C—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000179	0.00132	CbGpPWpGaD
Cyamemazine—Chlorprothixene—DRD1—attention deficit hyperactivity disorder	0.000178	0.014	CrCbGaD
Cyamemazine—CHRM2—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000177	0.0013	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000176	0.0013	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000172	0.00126	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000169	0.00125	CbGpPWpGaD
Cyamemazine—Thioridazine—DRD1—attention deficit hyperactivity disorder	0.000169	0.0132	CrCbGaD
Cyamemazine—CHRM2—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000168	0.00124	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000168	0.00124	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000168	0.00123	CbGpPWpGaD
Cyamemazine—Clomipramine—ADRA2A—attention deficit hyperactivity disorder	0.000166	0.0131	CrCbGaD
Cyamemazine—Acepromazine—DRD2—attention deficit hyperactivity disorder	0.000166	0.013	CrCbGaD
Cyamemazine—CHRM2—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000165	0.00122	CbGpPWpGaD
Cyamemazine—Promazine—DRD4—attention deficit hyperactivity disorder	0.000165	0.0129	CrCbGaD
Cyamemazine—CHRM2—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000164	0.00121	CbGpPWpGaD
Cyamemazine—Methotrimeprazine—DRD3—attention deficit hyperactivity disorder	0.000164	0.0129	CrCbGaD
Cyamemazine—Thioproperazine—DRD2—attention deficit hyperactivity disorder	0.000162	0.0127	CrCbGaD
Cyamemazine—HTR2A—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000162	0.0012	CbGpPWpGaD
Cyamemazine—Methotrimeprazine—DRD1—attention deficit hyperactivity disorder	0.000161	0.0126	CrCbGaD
Cyamemazine—Pipotiazine—DRD2—attention deficit hyperactivity disorder	0.00016	0.0125	CrCbGaD
Cyamemazine—HTR2A—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000159	0.00118	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000159	0.00117	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000158	0.00116	CbGpPWpGaD
Cyamemazine—Mesoridazine—DRD2—attention deficit hyperactivity disorder	0.000158	0.0124	CrCbGaD
Cyamemazine—HTR2A—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000158	0.00116	CbGpPWpGaD
Cyamemazine—Thioridazine—ADRA2A—attention deficit hyperactivity disorder	0.000157	0.0123	CrCbGaD
Cyamemazine—CHRM2—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000157	0.00115	CbGpPWpGaD
Cyamemazine—Trimipramine—SLC6A3—attention deficit hyperactivity disorder	0.000156	0.0123	CrCbGaD
Cyamemazine—HTR2A—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000156	0.00115	CbGpPWpGaD
Cyamemazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000155	0.00115	CbGpPWpGaD
Cyamemazine—Perphenazine—DRD1—attention deficit hyperactivity disorder	0.000155	0.0122	CrCbGaD
Cyamemazine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000155	0.00114	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000155	0.00114	CbGpPWpGaD
Cyamemazine—Trimipramine—ADRA2A—attention deficit hyperactivity disorder	0.000153	0.012	CrCbGaD
Cyamemazine—CHRM2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000153	0.00113	CbGpPWpGaD
Cyamemazine—Prochlorperazine—DRD2—attention deficit hyperactivity disorder	0.000153	0.012	CrCbGaD
Cyamemazine—HTR2A—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000153	0.00112	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00015	0.0011	CbGpPWpGaD
Cyamemazine—Methotrimeprazine—ADRA2A—attention deficit hyperactivity disorder	0.00015	0.0117	CrCbGaD
Cyamemazine—HTR2A—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000147	0.00108	CbGpPWpGaD
Cyamemazine—Chlorpromazine—DRD4—attention deficit hyperactivity disorder	0.000145	0.0114	CrCbGaD
Cyamemazine—CHRM2—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000144	0.00106	CbGpPWpGaD
Cyamemazine—Perphenazine—ADRA2A—attention deficit hyperactivity disorder	0.000144	0.0113	CrCbGaD
Cyamemazine—Promazine—DRD1—attention deficit hyperactivity disorder	0.00014	0.011	CrCbGaD
Cyamemazine—Fluphenazine—DRD2—attention deficit hyperactivity disorder	0.000138	0.0108	CrCbGaD
Cyamemazine—HTR2A—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000137	0.00101	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000135	0.000993	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000134	0.000989	CbGpPWpGaD
Cyamemazine—Propiomazine—DRD2—attention deficit hyperactivity disorder	0.000133	0.0104	CrCbGaD
Cyamemazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000132	0.000977	CbGpPWpGaD
Cyamemazine—Promazine—ADRA2A—attention deficit hyperactivity disorder	0.00013	0.0102	CrCbGaD
Cyamemazine—Acepromazine—HTR2A—attention deficit hyperactivity disorder	0.000128	0.0101	CrCbGaD
Cyamemazine—Clomipramine—SLC6A4—attention deficit hyperactivity disorder	0.000127	0.00996	CrCbGaD
Cyamemazine—Chlorprothixene—DRD2—attention deficit hyperactivity disorder	0.000126	0.00987	CrCbGaD
Cyamemazine—Thioproperazine—HTR2A—attention deficit hyperactivity disorder	0.000125	0.00985	CrCbGaD
Cyamemazine—Chlorpromazine—DRD3—attention deficit hyperactivity disorder	0.000125	0.00982	CrCbGaD
Cyamemazine—HTR2A—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.000125	0.00092	CbGpPWpGaD
Cyamemazine—Pipotiazine—HTR2A—attention deficit hyperactivity disorder	0.000123	0.00969	CrCbGaD
Cyamemazine—HTR2C—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000123	0.000909	CbGpPWpGaD
Cyamemazine—Chlorpromazine—DRD1—attention deficit hyperactivity disorder	0.000123	0.00964	CrCbGaD
Cyamemazine—CHRM2—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.000123	0.000903	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000122	0.000898	CbGpPWpGaD
Cyamemazine—Mesoridazine—HTR2A—attention deficit hyperactivity disorder	0.000122	0.00956	CrCbGaD
Cyamemazine—Thioridazine—DRD2—attention deficit hyperactivity disorder	0.000119	0.00934	CrCbGaD
Cyamemazine—HTR2C—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000118	0.000872	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000117	0.000864	CbGpPWpGaD
Cyamemazine—Trimipramine—SLC6A4—attention deficit hyperactivity disorder	0.000117	0.00917	CrCbGaD
Cyamemazine—HTR2A—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000117	0.000859	CbGpPWpGaD
Cyamemazine—Trimipramine—DRD2—attention deficit hyperactivity disorder	0.000116	0.00912	CrCbGaD
Cyamemazine—Imipramine—SLC6A3—attention deficit hyperactivity disorder	0.000116	0.00909	CrCbGaD
Cyamemazine—CHRM2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000114	0.000843	CbGpPWpGaD
Cyamemazine—Chlorpromazine—ADRA2A—attention deficit hyperactivity disorder	0.000114	0.00896	CrCbGaD
Cyamemazine—Methotrimeprazine—DRD2—attention deficit hyperactivity disorder	0.000114	0.00891	CrCbGaD
Cyamemazine—Promethazine—DRD2—attention deficit hyperactivity disorder	0.000112	0.00878	CrCbGaD
Cyamemazine—Trifluoperazine—DRD2—attention deficit hyperactivity disorder	0.00011	0.00866	CrCbGaD
Cyamemazine—Perphenazine—DRD2—attention deficit hyperactivity disorder	0.000109	0.00857	CrCbGaD
Cyamemazine—HTR2C—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000109	0.000803	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000107	0.00079	CbGpPWpGaD
Cyamemazine—Fluphenazine—HTR2A—attention deficit hyperactivity disorder	0.000107	0.00837	CrCbGaD
Cyamemazine—HTR2C—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000106	0.000785	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000106	0.000781	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000106	0.00078	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000106	0.000778	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000105	0.000775	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000104	0.000766	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000104	0.000765	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000104	0.000765	CbGpPWpGaD
Cyamemazine—Propiomazine—HTR2A—attention deficit hyperactivity disorder	0.000103	0.00805	CrCbGaD
Cyamemazine—HTR2C—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000102	0.000755	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000102	0.000751	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000102	0.00075	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000101	0.000744	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.0001	0.000737	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	9.9e-05	0.00073	CbGpPWpGaD
Cyamemazine—Promazine—DRD2—attention deficit hyperactivity disorder	9.84e-05	0.00772	CrCbGaD
Cyamemazine—Clomipramine—HTR2A—attention deficit hyperactivity disorder	9.76e-05	0.00766	CrCbGaD
Cyamemazine—Chlorprothixene—HTR2A—attention deficit hyperactivity disorder	9.71e-05	0.00762	CrCbGaD
Cyamemazine—HTR2C—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	9.59e-05	0.000707	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	9.55e-05	0.000704	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	9.47e-05	0.000698	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	9.42e-05	0.000695	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	9.31e-05	0.000686	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	9.3e-05	0.000685	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	9.25e-05	0.000682	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	9.2e-05	0.000678	CbGpPWpGaD
Cyamemazine—Thioridazine—HTR2A—attention deficit hyperactivity disorder	9.19e-05	0.00721	CrCbGaD
Cyamemazine—HTR2A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	9.17e-05	0.000676	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	9.08e-05	0.000669	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	9.04e-05	0.000666	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	9.02e-05	0.000665	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	9.01e-05	0.000664	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	9e-05	0.000663	CbGpPWpGaD
Cyamemazine—Trimipramine—HTR2A—attention deficit hyperactivity disorder	8.98e-05	0.00705	CrCbGaD
Cyamemazine—HTR2A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	8.9e-05	0.000656	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	8.85e-05	0.000652	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	8.85e-05	0.000652	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	8.84e-05	0.000652	CbGpPWpGaD
Cyamemazine—Methotrimeprazine—HTR2A—attention deficit hyperactivity disorder	8.78e-05	0.00689	CrCbGaD
Cyamemazine—CHRM2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	8.74e-05	0.000644	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	8.68e-05	0.00064	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	8.67e-05	0.000639	CbGpPWpGaD
Cyamemazine—Imipramine—SLC6A4—attention deficit hyperactivity disorder	8.66e-05	0.0068	CrCbGaD
Cyamemazine—Chlorpromazine—DRD2—attention deficit hyperactivity disorder	8.66e-05	0.0068	CrCbGaD
Cyamemazine—Promethazine—HTR2A—attention deficit hyperactivity disorder	8.64e-05	0.00678	CrCbGaD
Cyamemazine—Imipramine—DRD2—attention deficit hyperactivity disorder	8.62e-05	0.00676	CrCbGaD
Cyamemazine—HTR2A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	8.6e-05	0.000634	CbGpPWpGaD
Cyamemazine—Trifluoperazine—HTR2A—attention deficit hyperactivity disorder	8.53e-05	0.00669	CrCbGaD
Cyamemazine—CHRM2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	8.44e-05	0.000622	CbGpPWpGaD
Cyamemazine—Perphenazine—HTR2A—attention deficit hyperactivity disorder	8.44e-05	0.00662	CrCbGaD
Cyamemazine—HTR2A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	8.33e-05	0.000614	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	8.29e-05	0.000611	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	8.18e-05	0.000603	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	8.17e-05	0.000603	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	8.14e-05	0.0006	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	8.08e-05	0.000596	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	8.04e-05	0.000592	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	7.94e-05	0.000585	CbGpPWpGaD
Cyamemazine—Promazine—HTR2A—attention deficit hyperactivity disorder	7.6e-05	0.00597	CrCbGaD
Cyamemazine—HTR2A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	7.53e-05	0.000555	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	7.39e-05	0.000545	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	7.2e-05	0.00053	CbGpPWpGaD
Cyamemazine—Chlorpromazine—HTR2A—attention deficit hyperactivity disorder	6.69e-05	0.00525	CrCbGaD
Cyamemazine—HTR2C—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	6.69e-05	0.000493	CbGpPWpGaD
Cyamemazine—Imipramine—HTR2A—attention deficit hyperactivity disorder	6.66e-05	0.00523	CrCbGaD
Cyamemazine—HTR2C—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	6.29e-05	0.000464	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	6.25e-05	0.000461	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	6.14e-05	0.000452	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	6.07e-05	0.000448	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	5.85e-05	0.000431	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	5.7e-05	0.00042	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	5.66e-05	0.000417	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	5.57e-05	0.00041	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	5.5e-05	0.000405	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	5.46e-05	0.000403	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	5.36e-05	0.000395	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	5.18e-05	0.000382	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	5.12e-05	0.000378	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	5.08e-05	0.000374	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	4.99e-05	0.000368	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	4.92e-05	0.000363	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	4.83e-05	0.000356	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	4.83e-05	0.000356	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	4.77e-05	0.000352	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	4.75e-05	0.00035	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	4.69e-05	0.000346	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	4.45e-05	0.000328	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	4.37e-05	0.000322	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	3.59e-05	0.000264	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	3.06e-05	0.000225	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.9e-05	0.00014	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.65e-05	0.000122	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.62e-05	0.000119	CbGpPWpGaD
